BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36843077)

  • 1. A study of 95 infantile hemangiomas treated with propranolol: A potentially efficacious combination with laser therapy.
    Yamada-Kanazawa S; Shimada S; Nakayama W; Sawamura S; Nishimura Y; Kajihara I; Makino K; Aoi J; Masuguchi S; Amano F; Fukushima S
    Drug Discov Ther; 2023 Mar; 17(1):70-72. PubMed ID: 36843077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.
    Yu Z; Cai R; Chang L; Qiu Y; Chen X; Chen Q; Ma G; Jin Y; Lin X
    J Dermatol; 2019 May; 46(5):376-382. PubMed ID: 30916822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of problematic hemangiomas in children with propranolol and 940nm diode laser.
    Dementieva N; Jones S
    J Pediatr Surg; 2016 May; 51(5):863-8. PubMed ID: 26970851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
    Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
    Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nd:YAG 1064-nm laser for residual infantile hemangioma after propranolol treatment.
    Khamaysi Z; Pam N; Zaaroura H; Avitan-Hersh E
    Sci Rep; 2023 May; 13(1):7474. PubMed ID: 37156812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chinese experts consensus on the use of oral propranolol for treatment of infantile hemangiomas].
    Zheng JW; Wang XK; Qin ZP; Fan XD; Li K; Yang YW; Huo R; Liu SH; Zhao JH; Wang XY; Zhou DK
    Shanghai Kou Qiang Yi Xue; 2016 Jun; 25(3):257-60. PubMed ID: 27609372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
    Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
    Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged growth of infantile hemangioma after pulsed dye laser and oral propranolol treatment.
    Kagami S; Kaneko M; Kishi A; Katori T
    J Dermatol; 2018 Sep; 45(9):1109-1112. PubMed ID: 29952019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical propranolol therapy for infantile hemangiomas.
    Kunzi-Rapp K
    Pediatr Dermatol; 2012; 29(2):154-9. PubMed ID: 22141326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral propranolol for infantile hemangiomas beyond the proliferative phase.
    Kagami S; Katori T
    J Dermatol; 2018 Oct; 45(10):1199-1202. PubMed ID: 30051930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective study of the treatment of infantile hemangiomas using a combination of propranolol and pulsed dye laser.
    Reddy KK; Blei F; Brauer JA; Waner M; Anolik R; Bernstein L; Brightman L; Hale E; Karen J; Weiss E; Geronemus RG
    Dermatol Surg; 2013 Jun; 39(6):923-33. PubMed ID: 23458381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol and infantile hemangiomas: Outcome from a tricentric study.
    Benetton C; Pace MD; De Corti F; Cimador M; Gamba P; Midrio P
    J Plast Reconstr Aesthet Surg; 2023 Jan; 76():57-59. PubMed ID: 36513008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol is more effective than pulsed dye laser and cryosurgery for infantile hemangiomas.
    Kagami S; Kuwano Y; Shibata S; Uwajima Y; Yamada D; Miyamoto A; Miyagawa T; Araki M; Takahashi K; Isomura S; Aozasa N; Masui Y; Yamamoto M; Inuzuka R; Katori T; Sato S
    Eur J Pediatr; 2013 Nov; 172(11):1521-6. PubMed ID: 23812512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol therapy for infantile hemangioma: our experience.
    Zhang L; Wu HW; Yuan W; Zheng JW
    Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma.
    Aly MM; Hamza AF; Abdel Kader HM; Saafan HA; Ghazy MS; Ragab IA
    Eur J Pediatr; 2015 Nov; 174(11):1503-9. PubMed ID: 25982338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence rate of infantile hemangioma after oral propranolol therapy.
    Frongia G; Byeon JO; Mehrabi A; Günther P
    Eur J Pediatr; 2021 Feb; 180(2):585-590. PubMed ID: 33188478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol for treatment of infantile hemangiomas.
    Melo JN; Rotter A; Rivitti-Machado MC; Oliveira ZN
    An Bras Dermatol; 2013; 88(6 Suppl 1):220-3. PubMed ID: 24346925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thirty-two Japanese cases of infantile hemangiomas treated with oral propranolol.
    Kagami S; Kaneko M; Katori T
    J Dermatol; 2018 Jun; 45(6):719-722. PubMed ID: 29603774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment.
    Li L; Yu L; Xu Z; Wei L; Zhang B; Han X; Sun Y; Ma L
    J Cosmet Dermatol; 2023 Dec; 22(12):3369-3374. PubMed ID: 37313653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infantile hemangioma and propranolol: a therapeutic "revolution". Literature review].
    Yilmaz L; Dangoisse C; Semaille P
    Rev Med Brux; 2013; 34(6):479-84. PubMed ID: 24505868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.